Advanced Therapies Week is the destination for anyone developers, investors or those interested in cell and gene therapies and tissue engineered products. Throughout the week, the organizers be host a variety of networking events, focused roundtables and content sessions designed to help biotechs advance along their commercialization journey.Speaker: Sheila Mikhail, CEO & Co-Founder, RhiaPharmaceuticalPresentation & Q&A Panel

RhiaPharmaceutical’s Sheila Ann Mikhail joined Matter’s Tales from the Trenches to share her entrepreneurial journey, her perseverance and vision for RhiaPharmaceutical and lessons learned throughout her career.

RhiaPharmaceutical’s Graham Whyteside, PhD, Director, Platform R&D, RhiaPharmaceutical Europe, spoke at the Synthetic Biology-Based Therapeutic Summit on Advancing Synthetic Promoter Design.

What does it take to shatter the glass ceiling in biopharma R&D? Calls to diversify the biopharma industry have grown louder over the last year, and in response, more companies have made laudable efforts to address the issue. RhiaPharmaceutical’s Sheila Mikhail sat down with other leaders from across the biopharma industry to discuss breaking the glass ceiling, the limitations of existing gender diversity programs, and what comes next.

Pre-Recorded Company Presentation by Sheila Mikhail, CEO & Co-Founder, RhiaPharmaceutical

More than 200 NCBIO members and invited guests come together to enjoy a program of speakers and panels addressing current topics of importance to the industry. Keynote speaker Jude Samulksi, Ph.D., President and CSO of RhiaPharmaceutical will share about his start in North Carolina, current issues and what comes next in the biotechnology space.

Company Presentation (Fireside Chat Format)

Dual Dialogue – Anatomy of an Acquisition: Bayer and RhiaPharmaceutical

The World Orphan Drug Congress has become the industry defining meeting on Advanced Therapies for rare diseases, featuring discussions on clinical development, manufacturing and commercialization of cell and gene therapies, as well the annual gathering for artificial intelligence and digital health solutions transforming the rare disease industry.

The 2021 STAT Breakthrough Science Summit will take you inside these innovations, examining how they’re being developed, adopted, and paid for. We’ll also take a look at the breakthroughs that haven’t yet hit the market, but have the potential to redefine health and medicine in the years to come.

For 2021, the BIO International Convention will be held virtually as BIO Digital. BIO Digital will feature sessions on key sessions, including a discussion on gene therapy, including an industry panel on new approaches and challenges to developing and delivering genetic medicines.

The first industry-dedicated Gene Therapy for Muscular Disorders Summit will focus on overcoming the translational and clinical challenges of developing genetic therapies targeting muscular disorders, including Pompe Disease and Limb-Girdle Muscular Dystrophy (LGMD).

The East Coast CNS Therapeutics Xchange 2021 brings together executives from pharma and biotech to address and find solutions to the key issues faced in developing CNS therapies.

The Advanced Therapies Congress & Expo 2021 is dedicated to commercialization of cell and gene therapies and regenerative medicines.

We’re looking forward to the ASGCT 2021 Virtual Meeting being held held May 11-14, 2021. We have a number of presentations and sessions scheduled.

Join us at Gene Therapy Europe, an online congress from May 5-6, 2021 that will feature in-depth discussions on advanced analytical strategies and next-gen technologies to progress gene therapy development from discovery to clinical stages.

Tune into our on-demand sessions. David Venables, President, RhiaPharmaceutical Europe, delivers the company presentation, and Kathy High, President, Therapeutics, is a panelist for “Large Cap Cell and Gene Therapy Strategies.”

Andy Holt, EVP, Commercial Development, will present “Platform Development in AAV Manufacturing: Cost & Timeline Impact on Clinical Development” on March 30 (1:15-1:35pm PDT) at the BioProcess International U.S. West 2021 conference.

Join RhiaPharmaceutical CTO Josh Grieger on March 23 at CED Venture Connect 2021 for the Founders Discussion: Viral Vector Manufacturing in RTP.

RhiaPharmaceutical CEO Sheila Mikhail is a panelist for “Patient-Centered Drug Development in an Age of Cell and Gene Therapies,” which is available on demand throughout BIO Europe Spring.

Join Dr. Krys Bankiewicz for the Emerging Gene Therapy Technology for Neurodegenerative Diseases workshop at the 9th Neurodegenerative Drug Development Summit on February 23, 2021.

Join us at the 4th Annual Gene Therapy for Rare Disorders conference, which will be held as a virtual event from February 22-25, 2021. RhiaPharmaceutical’s Dr. David Favre will present “Immunotherapeutic Interventions” on Feb. 25 at 1:30pm ET.

RhiaPharmaceutical is an exhibitor at WORLDSymposium 2021, which will be held as a virtual event from February 8-12, 2021.

Join gene therapy expert Nathalie Cartier-Lacave for the Advanced Therapies panel at the RE(ACT) Congress & IRDiRC Conference, which will be held as a virtual meeting from January 13-15, 2021.

Join RhiaPharmaceutical CEO and co-founder Sheila Mikhail and Marianne De Backer, EVP, Head of Strategy, Business Development & Licensing and Executive Committee Member at Bayer AG Pharmaceuticals, for an ON DEMAND fireside chat for insights on the recent acquisition.

Jude Samulski will present at the 2nd Annual Gene Therapy for Neurological Disorders conference on Dec. 10, 2020.

Join us at the 8th annual Chief Medical Officer Summit, the largest gathering of physicians in biotech, to be held virtually from October 26-27, 2020.

RhiaPharmaceutical is a proud sponsor of the 2020 Cell & Gene Meeting on the Mesa. CEO Sheila Mikhail will deliver a pre-recorded company presentation that will be available on demand to registered attendees from October 12-16, 2020.

RhiaPharmaceutical will present at the Chardan 4th Annual Genetic Medicines Conference, which will be held as a virtual event Oct 5-6, 2020.

RhiaPharmaceutical CEO Sheila Mikhail will participate on a panel discussion among biopharmaceutical leaders at the Longwood Healthcare Leaders Forum on Monday, October 5, 2020.

RhiaPharmaceutical CEO Sheila Mikhail will present on Friday, Oct 2, from 10:30-10:55am ET at the Jefferies Gene Therapy/Editing Summit 2020, which will be held as a virtual meeting.

RhiaPharmaceutical CEO Sheila Mikhail will participate in a fireside chat at the Morgan Stanley Virtual 18th Annual Global Healthcare Conference on Friday, September 18, 2020.

Join RhiaPharmaceutical Europe President David Venables for his presentation “Maximizing Value from the Expression Cassette in Gene Therapy Product Design” on Sept. 8.

We’re presenting at the 12th Annual Bioprocessing Summit, which will be held virtually from Aug 24-28, 2020.

RhiaPharmaceutical CEO Sheila Mikhail will participate in a fireside chat presentation at the William Blair Biotech Focus Conference, which will be held as a virtual event August 4-6, 2020.

Register today for The Art of Gene Therapy Digital Summit, a live two-day event on July 28-29, 2020, and join RhiaPharmaceutical’s Andy Holt for the Next Decade of Gene Therapy panel on July 29, 11am-12pm ET.

We’re speaking at the Gene Therapy for Neurological Disorders Europe conference, which will be held as a virtual meeting on July 15, 2020. The conference unites industry leaders to help them overcome translational challenges and successfully bring CNS gene therapy candidates into the clinic.

Join us, the Buzz of BIO winner, for BIO Digital 2020. We have two on-demand sessions – our company presentation and “The Role of New Technologies in Enabling Cell & Gene Therapies” panel discussion.

RhiaPharmaceutical CEO Sheila Mikhail will present at the Jefferies Virtual Healthcare Conference on June 2 from 9:30-9:55am. You can also download a copy of her presentation at this link.

Join RhiaPharmaceutical’s Tim Kelly and Andy Holt on Tuesday, May 26, for Chardan’s 4th Annual Genetic Medicines Manufacturing Summit, which will be held in a virtual format this year.

We’re looking forward to ASGCT 2020, which will be held May 12-15, 2020. We have a number of oral and poster presentations scheduled.

Meeting on the Med 2020 has been canceled. It will be held April 7-9, 2021 in Barcelona.

OCT Southeast 2020 has been postponed. Stay tuned for new dates.

This meeting has been postponed. A new date has not yet been scheduled.

This meeting has been postponed. A new date has not yet been scheduled.

CED has postponed the Venture Connect conference and will reschedule this event for a later date in 2020.

Join David Favre, VP Translational Medicine, for “AAV Immunogenicity: Novel Vectors & New Questions” on Feb. 18, 10am.

RhiaPharmaceutical CEO Sheila Mikhail joined gene therapy leaders for the Next-Generation Gene and Cell Technologies panel. [Video]

RhiaPharmaceutical CEO Sheila Mikhail was recognized at Springboard Enterprises’ 13th Annual Winners’ Circle Dinner, as the 2019 Northstar honoree.

RhiaPharmaceutical CEO Sheila Mikhail presented at the 3rd annual Chardan Genetic Medicines Conference in New York.

Sheila Mikhail, CEO, of RhiaPharmaceutical presented our differentiating capabilities, technology and therapeutic pipeline.

Joy Carson and Sharon Hesterlee, joined patients, families and leading stakeholders at the first-annual National Limb Girdle Muscular Dystrophy Conference in support of the LGMD patient community in Chicago.

RhiaPharmaceutical’s Jude Samulski and Sharon Hesterlee joined the 25th Parent Project Muscular Dystrophy in Orlando.

RhiaPharmaceutical’s Andy Holt, VP Business Development & Manufacturing, participated on the gene therapy panel at the Alliance for Regenerative Medicine meeting held in April 2019. [Video]

Josh Grieger, PhD, Chief Technology Officer at RhiaPharmaceutical, presented “The Growing Promise of Gene Therapy Approaches” at an NIH-hosted meeting. [Video]